Comparison |
Alternate Manufacturer Number |
| | | 2417905 | 1410620 |
Container Type |
Single-Use Vial | Vial | Single-Dose Vial | Single-Dose Vial | Bottle |
Country of Origin |
Unknown | Italy | Unknown | Unknown | Unknown |
Dosage Form |
Injection | Injection | Injection | Injection | Capsule |
Generic Drug Code |
36908 | 17950 | 17950 | 17950 | 17941 |
NDC Number |
42367054032 | 78670000367 | 42023012306 | 00143929701 | 00115441101 |
Quantity |
| | | | 100 Capsules |
Strength |
250 mg | 20 mg | 20 mg | 20 mg | 25 mg |
Type |
Intravenous | Intravenous | Intravenous | Intravenous | |
Volume |
5 mL | 65 mL | 70 mL | | |
Application |
Malignant Hyperthermia Treatment Agent | Malignant Hyperthermia Treatment Agent | Malignant Hyperthermia Treatment Agent | Malignant Hyperthermia Treatment Agent | Malignant Hyperthermia Treatment Agent |
Generic Drug Name |
Dantrolene Sodium | Dantrolene Sodium | Dantrolene Sodium | Dantrolene Sodium | Dantrolene Sodium |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
UNSPSC Code |
51152024 | 51152024 | 51152024 | 51152024 | 51152024 |
Features and Benefits |
- RYANODEX is available in 20 mL vials containing a sterile lyophilized mixture of 250 mg dantrolene sodium for reconstitution with 5 mL sterile water for injection USP (without a bacteriostatic agent) to yield an orange colored injectable suspension
- Reconstitution yields 50 mg / mL
|
- Store unreconstituted product at 20 to 25 degrees C (68 to 77 degrees F)
- Revonto is supplied in 65 mL vials containing 20 mg dantrolene sodium, 3000 mg mannitol, and sufficient sodium hydroxide to yield a pH of approximately 9.5 when reconstituted with 60 ml sterile water for injection USP (without a bacteriostatic agent)
|
|
|
|